link
Bookmarks
Brain
Diagnosis
Pathology-Based Diagnoses
Infectious, Inflammatory, and Demyelinating Disease
Acquired Infections
Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy (PML)
Miral D. Jhaveri, MD, MBA
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Subscribe
0
5
7
0

KEY FACTS

  • Terminology

    • Imaging

      • Top Differential Diagnoses

        • Clinical Issues

          • Diagnostic Checklist

            TERMINOLOGY

            • Abbreviations

              • Progressive multifocal leukoencephalopathy (PML)
              • Classic PML (cPML)
              • Inflammatory PML (iPML)

            • Definitions

              • Subacute opportunistic infection caused by DNA John Cunningham polyomavirus (JC virus, JCV)

            IMAGING

            • General Features

              • Imaging Recommendations

                • CT Findings

                  • MR Findings

                    DIFFERENTIAL DIAGNOSIS

                      PATHOLOGY

                      • General Features

                        • Gross Pathologic & Surgical Features

                          • Microscopic Features

                            CLINICAL ISSUES

                            • Presentation

                              • Demographics

                                • Natural History & Prognosis

                                  • Treatment

                                    DIAGNOSTIC CHECKLIST

                                    • Image Interpretation Pearls

                                      Selected References

                                      1. López Sala P et al: Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy. Radiologia. 62(1):59-66, 2020
                                      2. Bartsch T et al: The spectrum of progressive multifocal leukoencephalopathy: a practical approach. Eur J Neurol. 26(4):566-e41, 2019
                                      3. Thurnher MM et al: Susceptibility-weighted mr imaging hypointense rim in progressive multifocal leukoencephalopathy: the end point of neuroinflammation and a potential outcome predictor. AJNR Am J Neuroradiol. 40(6):994-1000, 2019
                                      4. Grebenciucova E et al: Progressive multifocal leukoencephalopathy. Neurol Clin. 36(4):739-50, 2018
                                      5. Major EO: Progressive Multifocal leukoencephalopathy lesions and jc virus: the limits and value of imaging. JAMA Neurol. 75(7):789-90, 2018
                                      6. Berger JR: Progressive multifocal leukoencephalopathy. Handb Clin Neurol. 123:357-76, 2014
                                      7. Morrison VA: Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis. 59 Suppl 5:S360-4, 2014
                                      8. Wattjes MP et al: MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry. 86(7):793-8, 2014
                                      9. Zanoni BC et al: Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am. 28(3):501-18, 2014
                                      10. Shah R et al: Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol. 65(6):431-9, 2010
                                      11. Boster A et al: Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol. 66(5):593-9, 2009
                                      12. Carson KR et al: Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 10(8):816-24, 2009
                                      13. Boren EJ et al: The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun. 30(1-2):90-8, 2008
                                      14. Bergui M et al: Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 46(1):22-5, 2004
                                      15. Thurnher MM et al: Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol. 22(5):977-84, 2001
                                      16. Whiteman ML et al: Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 187(1):233-40, 1993
                                      Related Anatomy
                                      Loading...
                                      Related Differential Diagnoses
                                      Loading...
                                      References
                                      Tables

                                      Tables

                                      KEY FACTS

                                      • Terminology

                                        • Imaging

                                          • Top Differential Diagnoses

                                            • Clinical Issues

                                              • Diagnostic Checklist

                                                TERMINOLOGY

                                                • Abbreviations

                                                  • Progressive multifocal leukoencephalopathy (PML)
                                                  • Classic PML (cPML)
                                                  • Inflammatory PML (iPML)

                                                • Definitions

                                                  • Subacute opportunistic infection caused by DNA John Cunningham polyomavirus (JC virus, JCV)

                                                IMAGING

                                                • General Features

                                                  • Imaging Recommendations

                                                    • CT Findings

                                                      • MR Findings

                                                        DIFFERENTIAL DIAGNOSIS

                                                          PATHOLOGY

                                                          • General Features

                                                            • Gross Pathologic & Surgical Features

                                                              • Microscopic Features

                                                                CLINICAL ISSUES

                                                                • Presentation

                                                                  • Demographics

                                                                    • Natural History & Prognosis

                                                                      • Treatment

                                                                        DIAGNOSTIC CHECKLIST

                                                                        • Image Interpretation Pearls

                                                                          Selected References

                                                                          1. López Sala P et al: Cortical hypointensity in T2-weighted gradient-echo sequences in patients with progressive multifocal leukoencephalopathy. Radiologia. 62(1):59-66, 2020
                                                                          2. Bartsch T et al: The spectrum of progressive multifocal leukoencephalopathy: a practical approach. Eur J Neurol. 26(4):566-e41, 2019
                                                                          3. Thurnher MM et al: Susceptibility-weighted mr imaging hypointense rim in progressive multifocal leukoencephalopathy: the end point of neuroinflammation and a potential outcome predictor. AJNR Am J Neuroradiol. 40(6):994-1000, 2019
                                                                          4. Grebenciucova E et al: Progressive multifocal leukoencephalopathy. Neurol Clin. 36(4):739-50, 2018
                                                                          5. Major EO: Progressive Multifocal leukoencephalopathy lesions and jc virus: the limits and value of imaging. JAMA Neurol. 75(7):789-90, 2018
                                                                          6. Berger JR: Progressive multifocal leukoencephalopathy. Handb Clin Neurol. 123:357-76, 2014
                                                                          7. Morrison VA: Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis. 59 Suppl 5:S360-4, 2014
                                                                          8. Wattjes MP et al: MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry. 86(7):793-8, 2014
                                                                          9. Zanoni BC et al: Update on opportunistic infections in the era of effective antiretroviral therapy. Infect Dis Clin North Am. 28(3):501-18, 2014
                                                                          10. Shah R et al: Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol. 65(6):431-9, 2010
                                                                          11. Boster A et al: Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol. 66(5):593-9, 2009
                                                                          12. Carson KR et al: Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 10(8):816-24, 2009
                                                                          13. Boren EJ et al: The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun. 30(1-2):90-8, 2008
                                                                          14. Bergui M et al: Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 46(1):22-5, 2004
                                                                          15. Thurnher MM et al: Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol. 22(5):977-84, 2001
                                                                          16. Whiteman ML et al: Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 187(1):233-40, 1993